Spaulding Clinical to Perform TQT Study for Top-5 Pharma Company

West Bend, WI, March 8, 2010 – Spaulding Clinical Research, a new Phase I Unit designed for all types of pharmaceutical trials, including the most complex cardiac safety studies, announced today that it will serve as both the Phase I clinical site and the Core ECG Laboratory for an upcoming Thorough QTc (TQT) study from one of the world’s largest pharmaceutical companies. This Sponsor has already completed clinical pharmacology work with Spaulding Clinical and has deemed Spaulding more than capable of executing complex studies.

Spaulding Clinical has now successfully completed several TQT and less complex pharmacokinetic studies. Many of these studies included both Phase I Clinical Pharmacology and centralized cardiac safety services.

Spaulding Clinical CEO and Founder, Randy Spaulding said, “We are extremely proud of this award because it demonstrates the ultimate customer compliment: repeat business. Indeed, our study quality has proven to significantly exceed Sponsor expectations. Spaulding Clinical is truly redefining the quality standards for Phase I and centralized ECG services.”

Spaulding Clinical Chief Medical Officer, Dr. Jay Mason, added, “Our new unit has attracted attention not only because we can provide both a the full array of CRU servies and centralized ECG services, but in large part because all of our services are highly integrated electronically, resulting in efficiencies and error reduction that translate to more rapid study completion at a lower cost.”

Spaulding Clinical is a Phase I Clinical Research Unit and Electrocardiography Core Lab located in West Bend, Wisconsin offering a full range of services including TQT studies, first-in-human studies, multiple rising dose, bioavailability and bioequivalence, drug interaction, food effect studies, PK/PD characterization, and data collection and management. Spaulding Clinical also offers a full suite of Electrocardiography Core Lab and over-reading services with state-of-the- art technology and cardiac expertise. The company’s website is spauldingclinical.com